The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Osteoporosis Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
The global Osteoporosis Therapeutics market size is expected to reach US$ 12110 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Osteoporosis Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,, are propelling Osteoporosis Therapeutics market. Bisphosphonates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormones segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Distribution Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Osteoporosis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Osteoporosis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Osteoporosis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Osteoporosis Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Osteoporosis Therapeutics covered in this report include Warner Chilcott, Merck & Co., Roche, Novartis, Ono, Astellas Pharma, Procter & Gamble, Sumitomo Pharmaceuticals and Servier, etc.
The global Osteoporosis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai
Global Osteoporosis Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteoporosis Therapeutics market, Segment by Type:
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Global Osteoporosis Therapeutics market, by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Osteoporosis Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
The global Osteoporosis Therapeutics market size is expected to reach US$ 12110 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Osteoporosis Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,, are propelling Osteoporosis Therapeutics market. Bisphosphonates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormones segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Distribution Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Osteoporosis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Osteoporosis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Osteoporosis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Osteoporosis Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Osteoporosis Therapeutics covered in this report include Warner Chilcott, Merck & Co., Roche, Novartis, Ono, Astellas Pharma, Procter & Gamble, Sumitomo Pharmaceuticals and Servier, etc.
The global Osteoporosis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai
Global Osteoporosis Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteoporosis Therapeutics market, Segment by Type:
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Global Osteoporosis Therapeutics market, by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Osteoporosis Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Osteoporosis Therapeutics
1.1 Osteoporosis Therapeutics Market Overview
1.1.1 Osteoporosis Therapeutics Product Scope
1.1.2 Osteoporosis Therapeutics Market Status and Outlook
1.2 Global Osteoporosis Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Osteoporosis Therapeutics Market Size by Region (2018-2029)
1.4 Global Osteoporosis Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Osteoporosis Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Osteoporosis Therapeutics Market Size (2018-2029)
1.6.1 North America Osteoporosis Therapeutics Market Size (2018-2029)
1.6.2 Europe Osteoporosis Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Osteoporosis Therapeutics Market Size (2018-2029)
1.6.4 Latin America Osteoporosis Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Osteoporosis Therapeutics Market Size (2018-2029)
2 Osteoporosis Therapeutics Market by Type
2.1 Introduction
2.1.1 Bisphosphonates
2.1.2 Hormones
2.1.3 Strontium Ranelate
2.1.4 Raloxifene
2.1.5 Denosumab
2.1.6 Others
2.2 Global Osteoporosis Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Osteoporosis Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Osteoporosis Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Osteoporosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Osteoporosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Osteoporosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Osteoporosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Osteoporosis Therapeutics Revenue Breakdown by Type (2018-2029)
3 Osteoporosis Therapeutics Market Overview by Distribution Channel
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Online Pharmacies
3.1.3 Retail Pharmacies
3.2 Global Osteoporosis Therapeutics Market Size by Distribution Channel: 2018 VS 2022 VS 2029
3.2.1 Global Osteoporosis Therapeutics Historic Market Size by Distribution Channel (2018-2023)
3.2.2 Global Osteoporosis Therapeutics Forecasted Market Size by Distribution Channel (2024-2029)
3.3 Key Regions Market Size by Distribution Channel
3.3.1 North America Osteoporosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.2 Europe Osteoporosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.3 Asia-Pacific Osteoporosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.4 Latin America Osteoporosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.5 Middle East and Africa Osteoporosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
4 Osteoporosis Therapeutics Competition Analysis by Players
4.1 Global Osteoporosis Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoporosis Therapeutics as of 2022)
4.3 Date of Key Players Enter into Osteoporosis Therapeutics Market
4.4 Global Top Players Osteoporosis Therapeutics Headquarters and Area Served
4.5 Key Players Osteoporosis Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Osteoporosis Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Warner Chilcott
5.1.1 Warner Chilcott Profile
5.1.2 Warner Chilcott Main Business
5.1.3 Warner Chilcott Osteoporosis Therapeutics Products, Services and Solutions
5.1.4 Warner Chilcott Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Warner Chilcott Recent Developments
5.2 Merck & Co.
5.2.1 Merck & Co. Profile
5.2.2 Merck & Co. Main Business
5.2.3 Merck & Co. Osteoporosis Therapeutics Products, Services and Solutions
5.2.4 Merck & Co. Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Merck & Co. Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Osteoporosis Therapeutics Products, Services and Solutions
5.3.4 Roche Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Osteoporosis Therapeutics Products, Services and Solutions
5.4.4 Novartis Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Ono
5.5.1 Ono Profile
5.5.2 Ono Main Business
5.5.3 Ono Osteoporosis Therapeutics Products, Services and Solutions
5.5.4 Ono Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Ono Recent Developments
5.6 Astellas Pharma
5.6.1 Astellas Pharma Profile
5.6.2 Astellas Pharma Main Business
5.6.3 Astellas Pharma Osteoporosis Therapeutics Products, Services and Solutions
5.6.4 Astellas Pharma Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Astellas Pharma Recent Developments
5.7 Procter & Gamble
5.7.1 Procter & Gamble Profile
5.7.2 Procter & Gamble Main Business
5.7.3 Procter & Gamble Osteoporosis Therapeutics Products, Services and Solutions
5.7.4 Procter & Gamble Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Procter & Gamble Recent Developments
5.8 Sumitomo Pharmaceuticals
5.8.1 Sumitomo Pharmaceuticals Profile
5.8.2 Sumitomo Pharmaceuticals Main Business
5.8.3 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Products, Services and Solutions
5.8.4 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Sumitomo Pharmaceuticals Recent Developments
5.9 Servier
5.9.1 Servier Profile
5.9.2 Servier Main Business
5.9.3 Servier Osteoporosis Therapeutics Products, Services and Solutions
5.9.4 Servier Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Servier Recent Developments
5.10 Eli Lilly
5.10.1 Eli Lilly Profile
5.10.2 Eli Lilly Main Business
5.10.3 Eli Lilly Osteoporosis Therapeutics Products, Services and Solutions
5.10.4 Eli Lilly Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Eli Lilly Recent Developments
5.11 Pfizer
5.11.1 Pfizer Profile
5.11.2 Pfizer Main Business
5.11.3 Pfizer Osteoporosis Therapeutics Products, Services and Solutions
5.11.4 Pfizer Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Pfizer Recent Developments
5.12 Amgen
5.12.1 Amgen Profile
5.12.2 Amgen Main Business
5.12.3 Amgen Osteoporosis Therapeutics Products, Services and Solutions
5.12.4 Amgen Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Amgen Recent Developments
5.13 Chugai
5.13.1 Chugai Profile
5.13.2 Chugai Main Business
5.13.3 Chugai Osteoporosis Therapeutics Products, Services and Solutions
5.13.4 Chugai Osteoporosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Chugai Recent Developments
6 North America
6.1 North America Osteoporosis Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Osteoporosis Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Osteoporosis Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Osteoporosis Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Osteoporosis Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Osteoporosis Therapeutics Market Dynamics
11.1 Osteoporosis Therapeutics Industry Trends
11.2 Osteoporosis Therapeutics Market Drivers
11.3 Osteoporosis Therapeutics Market Challenges
11.4 Osteoporosis Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
